329D-1 Definitions

329D-2 Medical cannabis dispensaries; authorized; licensure

329D-2.5 Office of medical cannabis control and regulation;

established; duties

329D-3 Qualifications for licensure

329D-4 Medical cannabis dispensaries; license application

procedure and verification; fees

329D-5 Medical cannabis dispensaries; selection

329D-5.5 Sale or transfer of dispensary license

329D-6 Dispensary operations

329D-7 Medical cannabis dispensary rules

329D-8 Laboratory standards and testing; laboratory


329D-9 Manufacturing of medical cannabis products

329D-10 Types of manufactured cannabis products

329D-11 Advertising and packaging

329D-12 Background checks

329D-13 Dispensing limits

329D-14 Prohibited acts related to exceeding limits; fraud;


329D-15 Criminal offense; unauthorized access to retail

dispensing location

329D-16 Criminal offense; unauthorized access to production


329D-17 Prohibition of distribution of medical cannabis and

medical cannabis products to minors; penalties

329D-18 Diversion from dispensary or production center;


329D-19 Criminal offense; alteration or falsification of

medical cannabis dispensary records

329D-20 Law enforcement access to dispensary and production

center records

329D-21 Revocation and suspension of licenses

329D-22 Medical cannabis zoning

329D-23 Annual inspections, audits, and reports

329D-24 Cultivation of medical cannabis by qualifying

patients and primary caregivers

329D-25 Coordination among state and federal agencies

329D-26 Public education

329D-27 Administrative rules




Chapter heading amended by L 2017, c 170, 2.

Conforming amendments to title 11 of the Hawaii administrative rules; department of health to make conforming revisions to all documents, letterhead, websites, etc. by December 31, 2019. L 2017, c 170, 3, 4.

Personnel and contracts, exemption from chapter 76 (July 1, 2015 to June 30, 2025). L 2015, c 241, 14; L 2017, c 41, 11; L 2018, c 159, 4.

Repayment plan and schedule for deposits into medical marijuana registry and regulation special fund (not later than July 1, 2017). L 2015, c 241, 12.



Cross References


Medical cannabis; economic and other data; collection, see 201-13.9.

Medical cannabis testing and research programs, see 304A-1865.


Previous Vol06_Ch0321-0344 Next